PerkinElmer Launches New MicroBeta2 Microplate Counter Platform
Product News Jan 15, 2009
PerkinElmer, Inc. has announced the launch of its MicroBeta2 microplate counter platform, for enabling improved radiometric and luminescent detection in drug discovery and basic life science research.
The MicroBeta2 and MicroBeta2 LumiJET systems are the latest versions of PerkinElmer’s MicroBeta® line and add new and improved capabilities for researchers engaged in all major radiometric and luminescence applications. The MicroBeta2 platform is designed for robust performance with both radiometric and glow luminescent assays.
Sensitive detection is achieved through coincidence counting, for efficiency and low background for a wide variety of radionuclides. By combining liquid scintillation counter reliability with plate reader simplicity, the system allows savings in time and consumables, while reducing waste.
The MicroBeta2LumiJET Microplate Counter provides the assay development and profiling capabilities that pharma, biotech and academic customers require for luminescent assay platforms. The MicroBeta2 LumiJET system uses well-validated PerkinElmer technology to enable measurement of flash and glow luminescent technologies including Aequorin/Ca2+ measurement and dual label reporter gene assays, as well as classical GPCR filtration assays and scintillation proximity assays.